TheStreet downgraded shares of Mesa Laboratories (NASDAQ:MLAB) from a b- rating to a c rating in a research note issued to investors on Wednesday morning.

MLAB has been the subject of a number of other research reports. Zacks Investment Research upgraded shares of Mesa Laboratories from a strong sell rating to a hold rating in a report on Tuesday, January 9th. BidaskClub downgraded shares of Mesa Laboratories from a hold rating to a sell rating in a report on Tuesday, January 30th.

Mesa Laboratories (NASDAQ MLAB) opened at $131.13 on Wednesday. The company has a quick ratio of 1.97, a current ratio of 2.37 and a debt-to-equity ratio of 0.58. The stock has a market cap of $501.49, a PE ratio of -131.13 and a beta of 0.52. Mesa Laboratories has a twelve month low of $117.58 and a twelve month high of $169.80.

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Wednesday, February 28th will be issued a $0.16 dividend. The ex-dividend date is Tuesday, February 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.49%. Mesa Laboratories’s dividend payout ratio is presently -64.00%.

In other news, Director John Bradley Schmieder sold 3,000 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $132.27, for a total value of $396,810.00. Following the completion of the transaction, the director now owns 77,869 shares in the company, valued at approximately $10,299,732.63. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 15.70% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. PNC Financial Services Group Inc. increased its holdings in shares of Mesa Laboratories by 2.3% in the 2nd quarter. PNC Financial Services Group Inc. now owns 3,117 shares of the medical instruments supplier’s stock valued at $446,000 after purchasing an additional 71 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Mesa Laboratories by 7.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,564 shares of the medical instruments supplier’s stock valued at $367,000 after purchasing an additional 169 shares in the last quarter. Keybank National Association OH increased its holdings in shares of Mesa Laboratories by 13.2% in the 4th quarter. Keybank National Association OH now owns 3,850 shares of the medical instruments supplier’s stock valued at $479,000 after purchasing an additional 450 shares in the last quarter. Swiss National Bank increased its holdings in shares of Mesa Laboratories by 9.6% in the 2nd quarter. Swiss National Bank now owns 5,702 shares of the medical instruments supplier’s stock valued at $817,000 after purchasing an additional 500 shares in the last quarter. Finally, Wells Fargo & Company MN increased its holdings in shares of Mesa Laboratories by 19.9% in the 2nd quarter. Wells Fargo & Company MN now owns 3,326 shares of the medical instruments supplier’s stock valued at $476,000 after purchasing an additional 553 shares in the last quarter. Institutional investors and hedge funds own 71.29% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be viewed at https://theolympiareport.com/2018/02/11/mesa-laboratories-mlab-cut-to-c-at-thestreet.html.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.